Qiang Li
Lanzhou University Second Hospital(CN)Lanzhou University(CN)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Immunotherapy and Immune Responses, Biochemical and Molecular Research, Cancer Immunotherapy and Biomarkers, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial(2018)291 cited
- → Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer(2024)196 cited
- → A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma(2008)150 cited
- → Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes(2023)134 cited
- → Correlations of Tumor-associated Macrophage Subtypes with Liver Metastases of Colorectal Cancer(2013)91 cited
- → Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma(2010)90 cited